Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab?

Mammen, Andrew L

Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab? [electronic resource] - The Journal of rheumatology 06 2019 - 550-551 p. digital

Publication Type: Editorial; Research Support, N.I.H., Intramural; Comment

1499-2752

10.3899/jrheum.181392 doi


Humans
Hydroxymethylglutaryl CoA Reductases
Muscular Diseases
Rituximab